Genomic and metabolomic foundations of human-microbial symbiosis in the gut

NIH RePORTER · NIH · R01 · $705,658 · view on reporter.nih.gov ↗

Abstract

SUMMARY A microbial perspective of human development provides opportunities to both expand and refine our definitions of healthy postnatal growth. A corollary is that ensuring healthy microbiota development likely has long-term beneficial effects on host physiology, metabolism, and immunity. Little is known about the mechanisms that drive microbiota assembly (succession). Our central hypothesis is that the nutrient requirements of members of different stages of community development, and that changes in nutrient availability in the diet/gut, are key drivers of succession. Based on our previous studies, we postulate that (i) succession can be modeled in gnotobiotic mice, (ii) the nutrient requirements of community members can be deduced from in silico metabolic reconstructions based on their genome sequences; (iii) predictions from (ii) can be directly tested and refined through analyses of young gnotobiotic mice colonized with defined consortia of human gut bacterial strains representing different stages of community assembly. Based on our birth-cohort studies of healthy USA twins, we will model succession using a collection of sequenced bacterial stains cultured from a single (‘formula-fed’) cohort member. Strains have been grouped into consortia representing 3 stages of community development [Stage 1 (S1; months 1-2; when ‘weedy organisms’ are able to rapidly occupy a previously empty gut ecosystem), Stage 2 (S2, months 3-6; when organisms are rapidly acquired through dispersal from various environmental reservoirs as infants consume a milk-dominated diet), Stage 3 (S3, months 7-24; a period where fruits, vegetables and cereals become a more prominent part of the diet]. Our approach, described in 2 aims, involves multi-omic analyses of succession as a function of the availability of specified dietary nutrients [amino acids, B-vitamins (precursors of essential cofactors for myriad metabolic reactions), and carbohydrates (primary source of carbon/energy). Young GF mice colonized with the different stage consortia, introduced alone, together in various combinations, or in various sequences will be fed an ‘unmodified’ defined infant formula (IF) diet or IF derivatives where the representation of 4 different amino acids, or 4 different B vitamins, and several carbohydrates represented in fruits and vegetables are varied. The effects on consortium members will be characterized by measurements of their relative and absolute abundances (to assess competitiveness/fitness) in jejunum, cecum, colon, and feces and the results correlated with (i) amino acid, B vitamin, carbohydrate concentrations in these different gut compartments (targeted mass spectrometry), (ii) expression of genes involved in various metabolic pathways (microbial RNA-Seq), and (iii) our in silico subsystems-based approach for predicting metabolic phenotypes/nutrient requirements. Our approach, based on the ability to manipulate which organisms are introduced and when, under specified n...

Key facts

NIH application ID
9962371
Project number
5R01DK030292-37
Recipient
WASHINGTON UNIVERSITY
Principal Investigator
JEFFREY I GORDON
Activity code
R01
Funding institute
NIH
Fiscal year
2020
Award amount
$705,658
Award type
5
Project period
1982-01-01 → 2022-06-30